Adverse Events Following COVID-19 Vaccination among the Beneficiaries of Sikkim Manipal University: A Cross Sectional Study
Keywords:Covid-19 vaccine, Covishield, adverse events, AEFI, side effects
Context: Covid-19, an infection caused by SARS- CoV2 has claimed millions of lives since late 2019 with no curative measures. In India, 4 vaccines have been approved for use i.e. Serum Institute’s Covishield , Bharat Biotech’s Covaxin, GRIEM’s Sputnik V and Moderna’s Covid-19 vaccine.
Aims: This study aims to find the adverse events following Covishield vaccination among the beneficiaries of Sikkim Manipal University, Sikkim.
Settings and Design: A cross sectional study was conducted among the beneficiaries of Sikkim Manipal University to find out the adverse events following the first dose of vaccination.
Methods and Material: The data was collected using a self administered questionnaire when the beneficiaries came for their second dose of vaccination.
Statistical analysis used: Microsoft Excel and SPSS version 27 was used for statistical analysis.
Results: Out of 716 study participants majority i.e. 79.5% of the study participants developed adverse events following their first dose with maximum (73.8%) complaining of pain at the site of infection followed by fever (65.2%).
Conclusions: Vaccines may prevent diseases but it also brings about adverse effects, be it minor or major. Hence, many studies are required to study their full fledged side effects and the means to overcome them.
How to Cite
Copyright (c) 2021 Indian Journal of Community Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.